These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4042958)

  • 1. [Kinetics of the cell population in adenocarcinoma 755 after cyclophosphane administration and rate of tumor growth after an additional course of therapy with cyclophosphane and 6-mercaptopurine].
    Kiseleva EG; Volkova LM; Konovalova NP
    Eksp Onkol; 1985; 7(4):41-4. PubMed ID: 4042958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth characteristics of adenocarcinoma 755 recurrences in C57Bl/6 and (DBA/2 X C57Bl/6) F1 mouse strains].
    Soliakova TI; Kiseleva EG; Iakushchenko TN; Konovalova NP
    Eksp Onkol; 1988; 10(6):32-4. PubMed ID: 3243192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect, on kidney structure, of the use of antitumor preparations combined with diacarb and furosemide].
    Aref'eva AK; Rykov VA
    Farmakol Toksikol; 1982; 45(5):78-80. PubMed ID: 6890469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect high-altitude conditions on the antitumor activity of cyclophosphane and its action on lymphoid tissue cells].
    Kulish OP
    Eksp Onkol; 1985; 7(3):60-3. PubMed ID: 3160572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor efficacy and pharmacokinetic analysis of 4-hydroperoxycyclophosphamide in comparison with cyclophosphamide +/- hepatic enzyme effectors.
    Teicher BA; Holden SA; Goff DA; Wright JE; Tretyakov O; Ayash LJ
    Cancer Chemother Pharmacol; 1996; 38(6):553-60. PubMed ID: 8823498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nitroxyl radical Tempol as a modulator of toxic and antineoplastic effect of 6-mercaptopurine].
    Konovalova NP; D'iachkovskaia RF; Volkova LM; Varfolomeev VN
    Vopr Onkol; 1996; 42(3):57-63. PubMed ID: 8801743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A method of primary selection of antitumor agents].
    Karaivanova MKh
    Vopr Onkol; 1971; 17(2):62-6. PubMed ID: 5567711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Morphological and functional characteristics of hemopoiesis during the combined use of cyclophosphane with millimeter-band radio waves of nonthermal intensity].
    Zubenkova ES; Borodkina AG; Zinov'ev SV; Sevast'ianova LA
    Farmakol Toksikol; 1985; 48(6):49-53. PubMed ID: 4085630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM; Bartlett GL; Kreider JW; Biro TG
    Cancer Res; 1977 Apr; 37(4):1137-40. PubMed ID: 844041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunodepressants used in immune system pathology. I. Cyclosporin, cyclophosphane, azathioprine and mercaptopurine].
    Napolov IuK; Borisov KB
    Farmakol Toksikol; 1991; 54(4):80-7. PubMed ID: 1786839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of diacarb and furosemide in combination with cytostatics on the mitotic activity of tumor and intestines of rats with sarcoma 45].
    Aref'eva AK; Pashinskiĭ VG
    Farmakol Toksikol; 1977; 40(2):215-8. PubMed ID: 852564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in the ultrastructure of adenocarcinoma-755 under the influence of 6-mercaptopurine].
    Konovalova AL
    Vopr Onkol; 1971; 17(2):71-7. PubMed ID: 5567713
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of irinotecan in combination with 5-fluorouracil or etoposide in xenograft models of colon adenocarcinoma and rhabdomyosarcoma.
    Houghton JA; Cheshire PJ; Hallman JD; Lutz L; Luo X; Li Y; Houghton PJ
    Clin Cancer Res; 1996 Jan; 2(1):107-18. PubMed ID: 9816097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined effect of vilon and cyclophosphane on tumor transplants and lymphoid tissue explants in mice and rats of various age].
    Barykina OP; Iuzhakov VV; Chalisova NI; Kvetnoĭ IM; Konovalov SS
    Adv Gerontol; 2003; 12():128-31. PubMed ID: 14743610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of lymphocytes on the growth of transplanted adenocarcinoma of the colon in mice].
    Dontsov VI
    Eksp Onkol; 1989; 11(5):48-51. PubMed ID: 2791956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hematopoietic indices in rats with sarcoma 45 in the process of treatment with cytostatics and diuretic agents].
    Pashinskiĭ VG; Sedova KS
    Vopr Onkol; 1978; 24(3):83-6. PubMed ID: 644969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on chemotherapy in adenocarcinoma of the uterine cervix using xenografts transplanted in nude mice].
    Yamagishi M
    Nihon Sanka Fujinka Gakkai Zasshi; 1991 Feb; 43(2):165-72. PubMed ID: 1901582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjuvant chemotherapy in early breast cancer.
    Ejlertsen B
    Dan Med J; 2016 May; 63(5):. PubMed ID: 27127018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors.
    Schabel FM
    Cancer Res; 1969 Dec; 29(12):2384-9. PubMed ID: 5369685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.